Glynn County native, cancer survivor raising money for cause
Ansley Tripp, from St. Simons Island, is currently raising money in a fundraising effort to become the Lymphoma-Leukemia Society of Denver’s Woman of the Year. Tripp, who was diagnosed with Hodgkin’s Lymphoma in 2015 is raising money through the society’s website http://pages.mwoy.org/rm/denver18/atripp. The fundraising will continue until May when the winner will be announced. Tripp is currently studying pre-medicine in Denver. She is the daughter of Anna and Bruce Tripp of St. Simons Island. The money raised will go toward research and finding a cure for blood cancers, as well as other cancers.
“This research is also spilling over into areas such as Alzheimer’s, Parkinson’s disease, diabetes, and other non-communicable diseases that plague our friends and family. Needless to say, the work that they are doing is vitally important for those currently suffering and to our future health as well,” Tripp said.
Chiropractor to host free dinner, discussion
Wellman Family Healthcare, 124 Chapel Crossing Road, Brunswick, will host Dinner with the Doc, a free dinner held in which Dr. Wellman will also give a presentation on Three Ways to Maximize Your Health. Guests must be over 21 and should reserve a spot. For more information, visit the facility’s Facebook page.
An introductory transcendental meditation lecture is planned for 1 p.m. March 18, April 22 and May 20 in the casino building, 530 Beachview Drive, St. Simons Island. For more information, contact Allan Byxbe at 904-563-3115 or email firstname.lastname@example.org.
Wellness program offered
Coastal Regional Commission Area Agency on Aging will host its Living Well Coastal Wellness program from 9:30 a.m. to 5 p.m. March 15, 16, 22 and 23 at 1181 Coastal Drive, Darien. Attendees must go to all sessions. For more information, visit www.crc.ga.gov.
Cholesterol drug lowers risk of death, heart attack
ORLANDO, Fla. — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often.
Results on the drug, Praluent (PRALL-yoo-ent), were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago.
“It’s the ultimate outcome; it’s what matters to patients,” said study leader Dr. Philippe Gabriel Steg of Hospital Bichat in Paris.
But the benefit was small — 167 people would need to use Praluent for nearly three years to prevent a single death.
— The Brunswick News and